首页> 美国卫生研究院文献>Case Reports in Hepatology >Complete Remission after Sequential Therapy of Drug Eluting Beads Transarterial Chemoembolization and Liver Resection in Large Solitary Nodule Hepatocellular Carcinoma
【2h】

Complete Remission after Sequential Therapy of Drug Eluting Beads Transarterial Chemoembolization and Liver Resection in Large Solitary Nodule Hepatocellular Carcinoma

机译:序贯治疗药物洗脱小珠经大动脉结节性肝细胞癌经动脉化学栓塞和肝切除后完全缓解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hepatocellular carcinoma (HCC) is the fifth most prevalent and the second highest cause of death among cancer. The treatment of large solitary nodule HCC is still challenging. Transarterial chemoembolization (TACE) and liver resection are two modalities of therapy in HCC management. However, recurrence rate from each therapy is relatively high. We report a case of 46-year-old man diagnosed with large solitary nodule HCC, who was treated with drug eluting bead TACE (DEB-TACE) prior to liver resection. Studies about this combination are still limited and showed various results.
机译:肝细胞癌(HCC)是癌症中第五大最普遍的死亡原因,第二高的死因。大的孤立性结节性肝癌的治疗仍然具有挑战性。经肝动脉化疗栓塞(TACE)和肝切除术是HCC管理中的两种治疗方式。但是,每种疗法的复发率都较高。我们报告一例46岁的男子,被诊断患有大的孤立性结节性肝癌,在肝切除之前接受过药物洗脱珠TACE(DEB-TACE)的治疗。关于这种组合的研究仍然有限,并显示出各种结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号